495 related articles for article (PubMed ID: 24684211)
1. Oral doxycycline for Lyme neuroborreliosis with symptoms of encephalitis, myelitis, vasculitis or intracranial hypertension.
Bremell D; Dotevall L
Eur J Neurol; 2014 Sep; 21(9):1162-7. PubMed ID: 24684211
[TBL] [Abstract][Full Text] [Related]
2. Oral treatment of parenchymal central nervous system neuroborreliosis--are we there yet?
Halperin JJ
Eur J Neurol; 2014 Sep; 21(9):1147-8. PubMed ID: 24712767
[No Abstract] [Full Text] [Related]
3. Intravenous ceftriaxone compared with oral doxycycline for the treatment of Lyme neuroborreliosis.
Borg R; Dotevall L; Hagberg L; Maraspin V; Lotric-Furlan S; Cimperman J; Strle F
Scand J Infect Dis; 2005; 37(6-7):449-54. PubMed ID: 16012005
[TBL] [Abstract][Full Text] [Related]
4. Oral doxycycline versus intravenous ceftriaxone for European Lyme neuroborreliosis: a multicentre, non-inferiority, double-blind, randomised trial.
Ljøstad U; Skogvoll E; Eikeland R; Midgard R; Skarpaas T; Berg A; Mygland A
Lancet Neurol; 2008 Aug; 7(8):690-5. PubMed ID: 18567539
[TBL] [Abstract][Full Text] [Related]
5. Cerebrospinal fluid CXCL13 in Lyme neuroborreliosis and asymptomatic HIV infection.
Bremell D; Mattsson N; Edsbagge M; Blennow K; Andreasson U; Wikkelsö C; Zetterberg H; Hagberg L
BMC Neurol; 2013 Jan; 13():2. PubMed ID: 23294475
[TBL] [Abstract][Full Text] [Related]
6. Clinical characteristics and cerebrospinal fluid parameters in patients with peripheral facial palsy caused by Lyme neuroborreliosis compared with facial palsy of unknown origin (Bell's palsy).
Bremell D; Hagberg L
BMC Infect Dis; 2011 Aug; 11():215. PubMed ID: 21831262
[TBL] [Abstract][Full Text] [Related]
7. Common and uncommon neurological manifestations of neuroborreliosis leading to hospitalization.
Schwenkenbecher P; Pul R; Wurster U; Conzen J; Pars K; Hartmann H; Sühs KW; Sedlacek L; Stangel M; Trebst C; Skripuletz T
BMC Infect Dis; 2017 Jan; 17(1):90. PubMed ID: 28109263
[TBL] [Abstract][Full Text] [Related]
8. EFNS guidelines on the diagnosis and management of European Lyme neuroborreliosis.
Mygland A; Ljøstad U; Fingerle V; Rupprecht T; Schmutzhard E; Steiner I;
Eur J Neurol; 2010 Jan; 17(1):8-16, e1-4. PubMed ID: 19930447
[TBL] [Abstract][Full Text] [Related]
9. [A case of hemifacial paresis in a patient with Lyme neuroborreliosis treated with antibiotics in whom Borrelia meningitis developed].
Shimizu H; Haratani K; Miyazaki M; Kakehi Y; Nagami S; Katanami Y; Kawabata H; Takahashi N
Rinsho Shinkeigaku; 2016 Jul; 56(7):495-8. PubMed ID: 27356734
[TBL] [Abstract][Full Text] [Related]
10. Isolated Intracranial Hypertension as a Presentation of Pediatric Lyme Borreliosis: A Case Report and Literature Review.
Mah JM; Lo C; O'Connor MD
Pediatr Neurol; 2024 Mar; 152():196-199. PubMed ID: 38301323
[TBL] [Abstract][Full Text] [Related]
11. CXCL13 and neopterin concentrations in cerebrospinal fluid of patients with Lyme neuroborreliosis and other diseases that cause neuroinflammation.
Hytönen J; Kortela E; Waris M; Puustinen J; Salo J; Oksi J
J Neuroinflammation; 2014 Jun; 11():103. PubMed ID: 24920219
[TBL] [Abstract][Full Text] [Related]
12. Six versus two weeks treatment with doxycycline in Lyme neuroborreliosis: the protocol of a multicentre, non-inferiority, double-blinded and randomised controlled trial.
Solheim AM; Ljøstad U; Mygland Å
BMJ Open; 2019 Jun; 9(6):e027083. PubMed ID: 31201188
[TBL] [Abstract][Full Text] [Related]
13. Would Parents Consent to a Comparative Effectiveness Trial of Oral Doxycycline Versus Intravenous Ceftriaxone for the Treatment of Children with Lyme Meningitis?
Garro A; Koster M; LaRue M; Hipolito E; Congdon E; Burnett K; Cullen N; Nigrovic LE
Pediatr Infect Dis J; 2018 May; 37(5):e140-e142. PubMed ID: 28984721
[TBL] [Abstract][Full Text] [Related]
14. Remaining complaints 1 year after treatment for acute Lyme neuroborreliosis; frequency, pattern and risk factors.
Ljøstad U; Mygland A
Eur J Neurol; 2010 Jan; 17(1):118-23. PubMed ID: 19645771
[TBL] [Abstract][Full Text] [Related]
15. Cerebral vasculitis and stroke in Lyme neuroborreliosis. Two case reports and review of current knowledge.
Topakian R; Stieglbauer K; Nussbaumer K; Aichner FT
Cerebrovasc Dis; 2008; 26(5):455-61. PubMed ID: 18810231
[TBL] [Abstract][Full Text] [Related]
16. Spectrum of MRI findings in central nervous system affection in Lyme neuroborreliosis.
Volk T; Urbach H; Fingerle V; Bardutzky J; Rauer S; Dersch R
Sci Rep; 2024 May; 14(1):12486. PubMed ID: 38816506
[TBL] [Abstract][Full Text] [Related]
17. Clinical aspects of neuroborreliosis and post-Lyme disease syndrome in adult patients.
Pfister HW; Rupprecht TA
Int J Med Microbiol; 2006 May; 296 Suppl 40():11-6. PubMed ID: 16524775
[TBL] [Abstract][Full Text] [Related]
18. Follow-up of patients treated with oral doxycycline for Lyme neuroborreliosis.
Karkkonen K; Stiernstedt SH; Karlsson M
Scand J Infect Dis; 2001; 33(4):259-62. PubMed ID: 11345216
[TBL] [Abstract][Full Text] [Related]
19. Nervous System Lyme Disease.
Halperin JJ
Clin Lab Med; 2015 Dec; 35(4):779-95. PubMed ID: 26593257
[TBL] [Abstract][Full Text] [Related]
20. Doxycycline versus ceftriaxone for the treatment of patients with chronic Lyme borreliosis.
Ogrinc K; Logar M; Lotric-Furlan S; Cerar D; Ruzić-Sabljić E; Strle F
Wien Klin Wochenschr; 2006 Nov; 118(21-22):696-701. PubMed ID: 17160610
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
